SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Stochastics -- Ignore unavailable to you. Want to Upgrade?


To: sammy levy who wrote (325)3/4/1998 9:53:00 PM
From: Jeff Jordan  Respond to of 927
 
Biopharmaceutical firm Geron Corp. (Nasdaq:GERN - news) rallied $1 1/4 to $12 1/2 after announcing the
issuance of 8 new U.S. patents, the allowance of 11 U.S. patent applications, and the filing of 10 U.S., 6 foreign national, and 2
international patent applications relating to its proprietary programs for diagnosing and treating diseases...

Geron Corp. (GERN) announced the issuance of eight new U.S. Patents, the allowance of 11 U.S. patent
applications, and the filing of 10 U.S., six foreign national, and two international patent applications relating to its
proprietary programs for diagnosing and treating diseases based on the fundamental mechanism of cellular aging:
the control of telomere length by cell division and telomerase.
[ 12:30 p.m. EST, 3/4/98 ]